Covariates adjustment questioned conclusions of predictive analyses: an illustration with the Kidney Donor Risk Index

J Clin Epidemiol. 2021 Jul:135:103-114. doi: 10.1016/j.jclinepi.2021.02.007. Epub 2021 Feb 9.

Abstract

Objectives: We aimed to illustrate that considering covariates can lead to meaningful interpretation of the discriminative capacities of a prognostic marker. For this, we evaluated the ability of the Kidney Donor Risk Index (KDRI) to discriminate kidney graft failure risk.

Study design and setting: From 4114 French patients, we estimated the adjusted area under the time-dependent ROC curve by standardizing the marker and weighting the observations. By weighting the contributions, we also studied the impact of KDRI-based transplantations on the patient and graft survival.

Results: The covariate-adjusted AUC varied from 55% (95% confidence interval [CI]: 51-60%) for a prognostic up to 1 year post-transplantation to 56% (95% CI: 52-59%) up to 7 years. The Restricted Mean Survival Time (RMST) was 6.44 years for high-quality graft recipients (95% CI: 6.30-6.56) and would have been 6.31 years (95% CI: 6.13-6.46) if they had medium-quality transplants. The RMST was 5.10 years for low-quality graft recipients (95% CI: 4.90-5.31) and would have been 5.52 years (95% CI: 5.17-5.83) if they had medium-quality transplants.

Conclusion: We demonstrated that the KDRI discriminative capacities were mainly explained by the recipient characteristics. We also showed that counterfactual estimations, often used in causal studies, are also interesting in predictive studies, especially regarding the new available methods.

Keywords: Counterfactual prediction; Discrimination; Kidney Donor Risk Index; Kidney transplantation; Prognostic.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cohort Studies
  • Female
  • France
  • Graft Survival*
  • Humans
  • Kidney Transplantation / statistics & numerical data*
  • Male
  • Middle Aged
  • ROC Curve
  • Registries / statistics & numerical data
  • Reproducibility of Results
  • Risk Assessment
  • Risk Factors
  • Tissue Donors / statistics & numerical data*